ArticleMolecular and clinical oncology2025

The application of immunotherapy combined with taxanes in second‑line treatment of advanced HER2 negative gastric cancer.

Tianran Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.